ES2134768T3 - Composicion farmaceutica que comprende un fosfoazucar. - Google Patents

Composicion farmaceutica que comprende un fosfoazucar.

Info

Publication number
ES2134768T3
ES2134768T3 ES91901491T ES91901491T ES2134768T3 ES 2134768 T3 ES2134768 T3 ES 2134768T3 ES 91901491 T ES91901491 T ES 91901491T ES 91901491 T ES91901491 T ES 91901491T ES 2134768 T3 ES2134768 T3 ES 2134768T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
phosphazazar
opo3h2
combatting
alleviating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91901491T
Other languages
English (en)
Inventor
Matti Siren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Perstorp AB
Original Assignee
Perstorp AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perstorp AB filed Critical Perstorp AB
Application granted granted Critical
Publication of ES2134768T3 publication Critical patent/ES2134768T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UNA COMPOSICION FARMACEUTICA QUE CONTIENE UN FOSFOAZUCAR LA PRESENTE INVENCION SE REFIERE A UNA COMPOSICION FARMACEUTICA Y AL USO DE UN COMPUESTO DE LA FORMULA (I): (OH)6-P-(C4+NH5+MO)(OPO3H2)P, DONDE N = 1, 2 O 3, M = 1, 2, O 3, P = 1, 2, O 3 PARA LA PREPARACION DE UN MEDICAMENTO PARA PREVENIR, ALIVIAR O COMBATIR DIFERENTES CONDICIONES EN MAMIFEROS, INCLUIDO EL HOMBRE.
ES91901491T 1989-12-21 1990-12-18 Composicion farmaceutica que comprende un fosfoazucar. Expired - Lifetime ES2134768T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8904354A SE8904354D0 (sv) 1989-12-21 1989-12-21 A pharmaceutical composition

Publications (1)

Publication Number Publication Date
ES2134768T3 true ES2134768T3 (es) 1999-10-16

Family

ID=20377863

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91901491T Expired - Lifetime ES2134768T3 (es) 1989-12-21 1990-12-18 Composicion farmaceutica que comprende un fosfoazucar.

Country Status (11)

Country Link
EP (1) EP0506772B1 (es)
JP (1) JPH05502870A (es)
AT (1) ATE181505T1 (es)
AU (1) AU6971091A (es)
DE (1) DE69033183T2 (es)
DK (1) DK0506772T3 (es)
ES (1) ES2134768T3 (es)
GB (1) GB2255280A (es)
GR (1) GR3031119T3 (es)
SE (1) SE8904354D0 (es)
WO (1) WO1991009604A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0665080A (ja) * 1992-03-10 1994-03-08 Godo Shiyusei Kk α−グルコシダ−ゼ阻害剤を含有する、過血糖付随疾患の予防・治療剤、および保健食
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
KR100249136B1 (ko) * 1992-03-17 2000-05-01 말콤 카터, 리차드 케이쓰 퍼시 섬유증 질환의 치료방법
GB2299025B (en) * 1992-03-17 1996-11-27 British Tech Group Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye
US6566339B1 (en) 1995-08-04 2003-05-20 Renovo Limited Pharmaceutical composition
GB9516012D0 (en) * 1995-08-04 1995-10-04 Univ Manchester Pharmaceutical composition
US6093388A (en) * 1996-08-12 2000-07-25 Btg International Limited Mannose-6-phosphate composition and its use in treating fibrotic disorders
US6004958A (en) * 1997-02-05 1999-12-21 Fox Chase Cancer Center Compounds and methods for therapeutic intervention in preventing diabetic complications and procedures for assessing a diabetic's risk of developing complications and determining the efficacy of therapeutic intervention
JP4634027B2 (ja) * 2003-05-16 2011-02-16 花王株式会社 ビタミンｄ様活性代替用剤
US8267652B2 (en) 2004-08-30 2012-09-18 Lord Corporation Helicopter hub mounted vibration control and circular force generation systems for canceling vibrations
US7448854B2 (en) 2004-08-30 2008-11-11 Lord Corporation Helicopter vibration control system and rotary force generator for canceling vibrations
US7722322B2 (en) 2004-08-30 2010-05-25 Lord Corporation Computer system and program product for controlling vibrations
US8162606B2 (en) 2004-08-30 2012-04-24 Lord Corporation Helicopter hub mounted vibration control and circular force generation systems for canceling vibrations
US8090482B2 (en) 2007-10-25 2012-01-03 Lord Corporation Distributed active vibration control systems and rotary wing aircraft with suppressed vibrations
JP5171249B2 (ja) * 2005-03-23 2013-03-27 株式会社希少糖生産技術研究所 Ｄ−プシコースの血糖値日内異常上昇抑制の用途
JP5116071B2 (ja) * 2005-07-20 2013-01-09 帝國製薬株式会社 Ｄ−アロースおよびｄ−プシコースの抗神経因性疼痛効果の利用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6065M (es) * 1966-11-25 1968-05-27
GB1158456A (en) * 1967-06-13 1969-07-16 Prodotti Antibiotici Spa Preparations Containing Sugars
DE2508474A1 (de) * 1975-02-27 1976-09-02 Boehringer Mannheim Gmbh Infusions- und spuelfluessigkeiten zur behandlung von hirnoedemen
DE2629845A1 (de) * 1976-07-02 1978-01-05 Geb Graze Erika Graze Infusions- bzw. injektionsloesungen bzw. waessrige konzentrate zu deren bereitung zur therapeutischen restituion des zellulaeren energiestoffwechsels und der koerpereigenen regelfunktion
IT1143956B (it) * 1980-03-12 1986-10-29 Foscama Biomed Chim Farma Preparato di fruttosio-1,6-difosfato ad azione protettiva della membrana degli eritrociti in pazienti sottoposti a circolazione extracorporea
IT1156103B (it) * 1982-07-02 1987-01-28 Foscama Biomed Chim Farma Preparato di fruttosio-1,6-difosfato ad azione antiallergica

Also Published As

Publication number Publication date
AU6971091A (en) 1991-07-24
EP0506772B1 (en) 1999-06-23
EP0506772A1 (en) 1992-10-07
DK0506772T3 (da) 1999-11-22
JPH05502870A (ja) 1993-05-20
DE69033183D1 (de) 1999-07-29
GR3031119T3 (en) 1999-12-31
DE69033183T2 (de) 1999-11-18
GB2255280A (en) 1992-11-04
SE8904354D0 (sv) 1989-12-21
GB9212204D0 (en) 1992-08-12
WO1991009604A1 (en) 1991-07-11
ATE181505T1 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
ES2134768T3 (es) Composicion farmaceutica que comprende un fosfoazucar.
GB2255505A (en) Use of inositolphosphates for preparing medicament
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
FI854128A0 (fi) Foerfarande foer framstaellning av en foedoaemneskomposition som innehaoller inosotoltrifosfat och denna komposition.
NO308126B1 (no) Fosfolipidbasert forbindelse, anvendelse derav samt røntgenkontrastmiddel
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
ES2172600T3 (es) Composicion farmaceutica que comprende lamotrigina.
EP0415766A3 (en) Use of retinoids for reversing glucocorticoid-induced skin atrophy
ES2062292T3 (es) Un proceso para la preparacion del compuesto que tiene la estructura (7alfa,17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-in-3-ona.
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
SE9002342D0 (sv) Medicament
AU623805B2 (en) New use of anti-progestomimetic compounds
MX9102101A (es) Composiciones que contienen psyllium. composiciones que contienen psyllium.
ES2084878T3 (es) Sal colina de diclofenac, un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
SE9404568D0 (sv) The use of inositoltrisphosphate for the preparing of medicaments
MX166685B (es) Proceso para la preparacion de alcanosulfonamidas y arenosulfonamidas
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
ES2101311T3 (es) Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer.
ES2014445B3 (es) Composiciones farmaceuticas que contienen compuestos 5-fenil-1,3-dioxialquenilicos.
IT1224250B (it) Associzione del depiprazolo con la morfina
SE8602060D0 (sv) Farmaceutiska kompositioner som innehaller reducerad glutation
SE9303289D0 (sv) The use of inositoltrisphosphate for the preparing of medicaments
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 506772

Country of ref document: ES